Anaergia (ANRG) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Aug, 2026Opening remarks and agenda
Meeting opened with a welcome and overview of virtual procedures, including voting and Q&A protocols.
Quorum confirmed, and all required documents were distributed to shareholders.
Ohad Epschtein served as Chair, with Hani El-Kaissi as Secretary and Rosemary Colakic as scrutineer for the meeting.
Financial performance review
Consolidated financial statements for the years ended December 31, 2025 and 2024, and auditors' reports were presented; no shareholder action required.
Board and executive committee updates
The slate of directors up for election included Ohad Epschtein, Dr. Andrew Benedek, Dr. Diana Mourato Benedek, Peter Gross, Ronen Kantor, Assaf Onn, Stan Simmons, and CEO & Director, with bios provided in the Management Information Circular.
Election of directors conducted individually as per Majority Voting Policy.
Latest events from Anaergia
- Revenue nearly doubled, adjusted EBITDA positive for fourth straight quarter, and backlog expanded.ANRG
Q2 2026 - Q2 2026 revenue nearly doubled to $63.9M, with a $275M backlog and global market leadership.ANRG
Investor presentation - Integrated organic waste-to-RNG solutions drive growth amid global regulatory and market tailwinds.ANRG
Investor presentation - Revenue up 122% year-over-year, backlog at $265 million, and positive Adjusted EBITDA.ANRG
Q1 2026 - Q3 2025 delivered 77% revenue growth, positive adjusted EBITDA, and a $287M backlog.ANRG
Q3 2025 - Revenue up 36.8%, gross margin at 32.5%, and backlog up 137%, supporting strong growth momentum.ANRG
Q2 2025 - Improved EBITDA, reduced losses, and strong cash position support a capital-light growth strategy.ANRG
Q3 2024 - Record $200M backlog, improved margins, and global contracts drive strong growth.ANRG
Q1 2025 - Improved margins, reduced losses, and a $103.3M backlog support strong 2025 growth.ANRG
Q4 2024